First, CD137 on tumor cells likely acts as a platform for immobilizing rhCD137L-MSNs, which in turn supports the formation of dense, hyper-clustered CD137 signaling complexes in T cells at the points of contact with CD137-expressing tumor cells. Here, TNFRSF9 is linked to neoplasm.